<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 164 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page163.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=164">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 164 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 164</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=164"><img src="../thumb/164.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Cardio-Vascular Agents - 7.7.2                                                 2020-04 / 133
       next lev.aft.4 wks.if necess. Maj.pts. control.on 10 mg dos.  riph.oed., vomit., pancreatit., hepatit., cholestat.jaund., alopec., Stev.  /prev. musc.toxic.hist.with anoth.HMG-CoA reduct. inhibit. or fibrate/
       Fin.titrat.to max.40 mg dos.only aft.another 4-wk period. Max.dos.  John. syndr./tox.epiderm.necrolys., erythema multiforme, myopathy,   alcoh.abuse/ situat.where incr. plasma lev.poss.occur/Asian pts./
       of 40 mg only to be consider.in sev.hypercholesterolaem.with high   myosit., rhabdomyolys.with/without ren.impairm., musc.cramps,   concom.fibrat., other HMG-CoA reduct.inhibit.hypersens., act. liv.
       CV risk. Specialist supervis.then recomm.  impot., malaise, fatig., periph.oed., accid.injur., tend.rupt. Freq.un-  dis., concom.ciclospor., myopathy, safety & effic.in childr. not est.,
       Prim.hypercholesterolaem./mix.dyslipidaem. & isol.hyper-  known: Insomn., hypoaesthes., sinusit., pharyngit.,  safety in pregn.& lactat.not est., sev. ren.impairm.
       triglyceridaem: Recomm.start.dos: 5 mg (ie.half 10 mg tab) once   Special precautions: Allow 1 mnth.interv.aft. discont. ther.bef.  Side effects: Freq: Constip., naus., abdom.pain, asthen., oed., my-
       dly. Start.dos.of 20 mg may be consid.in sev. hypercholesterolaem  plann.pregn., substant.alcoh. consumpt. &/ liv.dis.hist., limit.treatm.  alg., prurit., rash, urticar. Less freq: Cough, dyspn., hypersens.pneu-
       Homozygous familial hypercholesterolaem: Start.recomm.  exper.in paeds. in homozyg.famil.hypercholesterolaem., mod. to sev.  monit., hypersens. reacts.incl.angoed., photosens., flush., alopec., incr.
       dos: 20 mg once dly.          hepat.dysfunct., lipid lower.ther.to be compon. of multip.risk fact.  hepat.transaminas., hepatit., jaund., cholestas., myopathy (incl. my-
       Concom.ther.: Addit.effic.shown.with concom. fenofibrate in   intervent.where atherosclerot. vasc.dis.risk pres., lipid-alter.agents   ositis), rhabdomyolys., pancreatit., diarrh., proteinur., nephrit., sex.dys-
       lower.triglycerid.& may incr. HDL-C lev. with niacin. Bile acid se-  used in addit.to diet restrict.in saturat.fat & cholester. only when   funct., gynaecomast. Unknown freq.: Incr.hepat.transaminas./CK lev.
       questrant.can be used.        respons.to diet & other non-pharmacol. meas.inadeq., excl.second.  Warnings and special precautions: Consid. 40 mg admin.only in
       Init. ther.with 5 mg once dly.& do not exceed 20 mg once dly with   caus.prior to init. ther. & meas.lipid profile, monit.liv.funct.bef.& dur.   sev.hypercholesterolaem.& high CV risk who do not achiev.treatm.
       concom.gemfibrozil.           treatm., discont.ther.if ALT & AST persist.&gt;3 times ULN/ ac.ser.condit.  goal on 20 mg treatm./alt. ther., women of childbear. potent.to use
       Contraindications: Other HMG-CoA reduct. inhibit.hypersens., act.  suggest.of myopathy or risk fact.predisp.to ren.fail.developm.second.  adeq.contracept., predispos. myopathy/ rhabdomyolys. fact.eg.ren.
       liv.dis., unexplain.persist. ser.transaminas.elev/if elev.exceed.3XULN,   to rhabdomyolys., sev.ren.impairm., musc.disord.hist., hypothyroid.,   impairm./ hypothyroid./heredit.musc.disords or hist.thereof/ hist of
       sev.ren.impairm., myopathy, concom. cyclospor., pregn.& lactat.,   age &gt;70 yrs., musc.toxic.hist.with anoth. HMG-CoA reduct.inhibit./  musc.toxic.with another HMG-CoA reduct. inhibit.or fibrate/alcoh.
       women of childbear.potent.not using adeq.contracept., predispos.  fibr., concom. fibr. use & when incr.plasma lev.may occur, concom.   abuse/&gt;70 yrs./ situat. where incr.plasma lev.poss./concom.fibrat.,
       myopathy/ rhabdomyolys. fact.eg. ren.impairm./hypothyroid./ heredit.  digox./ warfar., Type 2 diab., pt.to report unexpl. musc. pain/tendern./  concom. protease inhibits.in HIV infect., monit.INR with warfar.,
       musc.disords or hist.thereof/hist of musc. toxic.with another HMG-  weakn.esp.with fev./malaise, discont. ther.if myopathy diagn./susp./  admin.antacid 2 hrs.aft.ther., paed. exper.limit.to small no.of childr.
       CoA reduct.inhibit.or fibrate/alcoh.abuse, situat.where incr.plasma   mark.elev. CPK lev., pts.without card.heart fail.who had stroke/ TIA   8 yrs.& old.with homozyg. famil.hypercholesterolaem., excess. alcoh.
       lev.poss./Asian pts./concom.fibrates, concom. protease inhibit.in HIV   with.preced.mnths.& were init.on atorvastatin 80 mg appear to have   consumpt., liv.dis.hist., sev.liv.impairm., incr. syst.expos.in Asian pts.,
       pts not recomm., 40 mg dos.with concom.fibrate, not recomm.in childr.  high. incid.of haemorrhag. stroke, avoid concom. diltiazem HCl/ grape-  liv.enzyme tests bef.init. ther.& thereaft., ther.to be interrupt.if ser.liv.
       due to insuffic.data on safety & effic., 40 mg dos.in mod.ren.impairm.  fr.juice/rifampicin, lact.intol.  injur. with clinic.sympt.&/hyperbilirubinaem.or jaund. occurs, Type 2
       Side effects: Anaem., hypersens.incl.angioed., infect., diab.mellit.,   Interactions: Incr.myopathy risk with immunosuppress./ fibr.acid   diab., ren.funct.monit.in pts.treat. with 40 mg dos., monit.CK lev.if
       psych.disords., headache, dizzin., vertigo, vomit., polyneuropathy, par-  derivats./nicotin.acid & cytochrome P450 inhibits.e.g.macrolid./  S&S suggest.of myopathy pres.& discont.ther if myopathy is diagn./
       aesthes., cognit.impairm.incl.amnes., ang. pect., hypertens., vasodi-  azole antifung./ protease inhibits., fucid.acid, decr. plasma conc.  susp., incr.myosit.& myopathy incid.report. in pts.on other HMG-CoA
       lat., pharyngit., asthma, bronchit., dyspn., dyspeps., rhinit., sinusit.,   with antacid susp.cont.Mg & Al hydrox./ colestipol, plasma conc.of   reduct.inhibit.tog.with ciclospor./fibrates/fenofibrate/gemfibrozil/
       GI disturbs., pancreatit., incr.ser.gluc.lev., jaund., hepatit., prurit., rash,   digox.incr., incr. plasma lev.with cytochrome P450 3A4 inhibits., incr.  nicotin. acid/azole antifung.& macrolide antibiot., condit. suggest.
       urticar., ecchymos., Stev.-John. syndr., myalg., myopathy incl.myosit.,   AUC of norethindrone/ ethinyloestrad., incr.AUC with diltiazem, incr.  of myopathy/pre-dispos.to ren.fail. developm. second.to rhabdo-
       rhabdomyolys., arthralg., arthrit., back pain, hyperton., haematur., pro-  conc. with grapefr.juice, reduc.conc.with rifampicin.  myolys., pts.taking var. prot.inhibits.concom.with ritonavir, lact.intol.
       teinur., asthen., incr. liv.transaminas.& CK.  VATICOL XL,(Aspen Pharmacare)   Interactions: Plasma conc.on avg.7xhigh.with concom. ciclosporin,
       Special precautions: Consid.40 mg admin.only in sev. hypercholes-  Pharmacare [P/S]  Cmax & AUC 2x incr.with gemfibrozil, incr.system.expos.& adverse effs.
       terolaem.(excl.heterozygous familial hypercholesterolaem) & high CV   Fluvastatin sod.equiv.to fluvastatin  with var. protease inhibit.in combinat.with ritonavir, antacids cont.Mg
       risk who do not achiev.treatm.goal on 20 mg treatm./alt. ther., women   Indications: Adjunct.to diet for reduct.of elev.tot.& LDL-cholesterol   & Al decr.plasma conc., decr. AUC & C max with erythromycin, incr.ethi-
       of childbear.potent.to use adeq. contracept., risk vs.benefit predispos.  lev. in prim. hypercholesterolaem. when respons.to diet & other meas.  nyl oestrad. & norgestrel AUC with oral contracept.& simil.eff. with
       myopathy/ rhabdomyolys.fact.eg. ren.impairm./hypothyroid./ heredit.   inadeq., slow.of coron.arteroscleros. progress.in prim. hypercholester-  HRT cannot be excl., poss.rhabdomyolys.with concom. ezetimibe.
       musc.disords or hist.thereof/hist of musc. toxic. with another HMG-  olaem. & coron. heart dis.who do not respond.to diet.  ZOCOR, MSD [P/S]
       CoA reduct.inhibit.or fibrate/ alcoh.abuse/&gt;70 yrs., situat.where incr.   (S4) TABS, 42/7.5/0805  Simvastatin.
       plasma lev.poss./concom.fibrates, monit.INR with warfar., incr.myos-  718208-001: 80 mg, 28, R246,74  Indications: Decr.risk of tot.mortal.by reduc. coron. death/decr.risk
       it.& myopathy incid.report.in pts.on other HMG-CoA reduct.inhibit.  Dosage: Admin.in the even. & swallow whole. Init.& contin.  of non-fat.MI/decr.risk for undergo. myocard.revasculat.proced.&
       tog.with ciclospor./fibrates/ fenofibrate/gemfibrozil/nicotin. acid/  cholesterol-low.diet ther.bef.& dur. treatm.tog.with weight contr.&   slow. coron. artheroscleros.progress in pts.with est.coron.heart dis.
       azole antifung.& macrolide antibiot., rhabdomyolys. with ezetimibe   physic.exerc. program  & hypercholesterolaem.unrespons.to diet, diet adjunct for reduct.
       report., ser. congenit. defects.poss.if taken dur.pregn., excret. in rats   Admin.80 mg once dly.at night. Dos.adjustm. accord. to respons. at   of elev.tot.cholester.& LDL-cholester. in prim.hypercholesterolaem./
       breastmilk, dos.above 10 mg in sev.hepat. impairm.as incr.in system.  interv.of 4 wks or more.   heterozygous famil.hypercholesterolaem.or mix. hyperlipidaem. when
       expos.observ., incr. system. expos.in Asian pts., excess.alcoh. con-  Contraindications: Act.liv.dis., persist.unexpl. elev. ser.transami-  respons.inadeq.to diet & other nonpharmacolog.meas.
       sumpt., liv.dis.hist., treat.underly.hypothyroid./ nephrit. syndr.bef.init.  nas.& creatine-phosphokin., sev. ren.insuffic., pregn., lactat., concom.  (S4) TABS. W/7.5/350, 351, 31/7.5/447.
       ther., ren.funct.monit.in pts. treat. with 40 mg dos., monit.CK lev.if S&S   fibrates or gemfibrozil, no data avail.in homozygous famil. hypercho-  783951-019: 10 mg, 28, R106,19
       suggest. of myopathy pres.& discont.ther if myopathy is diagn./susp.,   lesterolaem., not test.in pts.&lt;18 yrs.  783978-006: 20 mg, 28, R106,19
       condit.suggest.of myopathy/ pre-dispos.to ren.fail.developm. second.   Side effects: Headache, insomn., GI disturbs., revers.incr.ser.  836265-009: 40 mg, 30, R106,19
       to rhabdomyolys., discont.if interstit.lung dis. developm.suspect., type   transamin.lev., hepatit., skin rash, urticar., myalg., myosit., rhabdo-  Dosage: Hypercholesterolaem: 10 mg/day in even. Adjust dos.if
       2 diab.as worsen. glycaem. control report., memory loss/impairm. re-  myolys., ac.ren. fail.assoc.with rhabodmyolys  reqd., at interv.of not less than 4 wks., to a max.of 80 mg/ day in even.
       port. in pts.over 50 gen.revers.upon discontinuat.  Special precautions: Hepat.dis.hist., alcoholism, monit.liv.funct.  Coron.heart dis: 20 mg/day in even. Adjust dos.as above if requir.
       Drug interactions: AUC on aveg.7xhigh.with concom. ciclosporin,   bef.& dur.treatm., discont.if ser. transamin.lev.progress.partic.if rise   Concom.ther: Bile acid sequestr: Admin.1 hr. bef./4hrs.aft.
       incr.INR with vit.K antagon. (eg.warfar.), Cmax & AUC 2x incr.with   to 3xULN, discont. if CK lev.are marked.elev.or if myopathy is diagn./   cholestyramine. Cyclosporin, fibrates or niacin: Max.recomm.
       gemfibrozil, incr.system.expos.& adverse effs.with var. protease   suspect., concom.immunosuppr.agents /cyclosporin/ gemifibrozil/  dos: 10 mg/day.
       inhibit.in combinat.with ritonavir, antacids contain Mg & Al decr.  fibrates/niacin/ macrolide antibiot.or azole antifung.assoc.with incr.   Contraindications: Act./chron.liv.dis., unexplain. persist.serum
       plasma conc., decr. AUC (o-t) & Cmax with erythromycin, incr.ethi-  myopathy risk, pts.to report unexplain.musc. pain/ weakn./tendern.  transaminas.elev., pregn.& lactat., female pts.of child-bear.potent.,
       nyl oestrad.& norgestrel AUC with oral contracept.& simil.eff.with   esp.if accompany.by malaise & fev., withhold tempor.in ac./ser.con-  safety & effic.in paed. pts.not est.
       HRT cannot be excl.           dit. predispos. to ren.fail.developm.second.to rhabdomyolysis, freq.  Side effects: GI disturbs., CNS effs., skin reacts., bld.dyscras.,
       VASTOR, (Unicorn) Mylan [P/S]  INR/prothromb.monit.with concom. warfar./other coumar.deriv.,   alopec., musc.cramps, myalg., pancreatit., paraesthes., rhabdo-
                                                                  myolys., hepatit., jaund., myopathy, mass gain, periph.neuropathy,
       Atorvastatin                  admin.2-4 hrs. aft. cholestyramine/colestipol, adeq. contracept. in
       Indications: Adjunct to diet to reduc.elev.tot.-cholesterol/ LDL-  women of childbear.potent., discont. ther. if a woman becom.pregn.  hypersens. syndr., mark.persist.ser.transaminas. incr., liv.funct.ab-
                                                                  norm.& incr.ser.CK
       cholesterol/apolipoprot.B & triglyceride levs.in prim.hypercholes-  Drug interactions: INR incr.with warfarin, poss. elev.of ser.digox.
       terolaem./ heterozygous familial hypercholesterolaem. & mix.dys-  lev., bioavailabil.reduc.with rifampicin.  Special precautions: Fetotox.& teratogen.in animals, not effect.in
                                                                  sev.hypertriglyceridaem., concom.cholester.-lower.diet to be maint.
       lipidaem., reduc.tot.-cholesterol & LDL-cholesterol in homozygous   VUSOR, (Cipla Medpro) Watson [P/S]
       familial hypercholesterolaem. as adjunct to other lipid low. treatm.  Rosuvastatin.  bef.& dur. treatm., monit.cholester.lev.dur.ther., sev.ren. insuff., liv.
                                                                  funct.tests.recomm.bef.start.treatm.& period. thereaft.esp.pts.ti-
       or if such treatm.unavail.    Indications: Adjunct.to diet & exerc.when respons. inadeq in prim.
       (S4) TABS. 45/7.5/0527, 0528, 0529, 0530  hypercholesterolaem., mix. dyslipidaem./ isolat. hypertriglyceridaem.   trat.to 80 mg dos., substant. alcoh.consumpt., liv.dis.hist., monit.for
                                                                  myopathy & discont.if myopathy occurs/suspect., concom. immuno-
       718933-001: 10 mg, 30, R34,02  (incl. Fredrickson Type 11a, 11b & 1V), homozygous familial hyper-  suppress./fibrates/lipid low.dos niacin, withdr.tempor.in pts receiv.
       718934-001: 20 mg, 30, R36,25  cholesterolaem.alone or as adjunct. to diet & other lipid low.treatm.
       718935-001: 40 mg, 30, R63,60  (S4) TABS. 45/7.5/0310, 0311, 0312, 0313  cyclospor.if system. azole derivat.antifung.reqd.
                                                                  Drug interactions: Anticoag.eff.of coumar. anticoags. enhanc.,
       718936-001: 80 mg, 30, R129,44  719081-001: 5 mg, 30, R88,50
       Dosage: Cholester.low.diet in place. Indiv.accord. to basel.LDL-C lev./  719082-001: 10 mg, 30, R145,50  digoxin lev.incr., propranolol decr. mean C max.conc., itraconazole/
                                                                  ketoconazole/ erythromyin/ clarithromycin/HIV protease inhibits. &
       ther.goal/pt.respons. Dos. adjustm. aft. 4 wks.or more interv. Max.  719083-001: 20 mg, 30, R219,72
       recomm. dos: 40 mg once dly.  719084-001: 40 mg, 30, R267,23  nefadozone incr.myopathy risk.
       Prim.non-famil.hypercholesterolaem.& combin. (mix.)hy-  Dosage: Cholester.low.diet in place. Indiv. accord. to ther.goal &   ZUVAMOR, (Aspen Pharmacare) AstraZeneca [P/S]
       perlipidaem: Usual.contr.with 10 mg once dly. Therap.respons.  pt.respons. Recomm.start.dos: 5 mg once dly. Dos.range: 5-40 mg   Rosuvastatin.
       evid.within 2 wks. Max.respons.usual.achiev.within 4 wks.& maint.   once dly. Maj. pts. control.on 10 mg dos. Dos.adjustm.can be made   Indications: Adjunct.to diet & exerc.when respons. inadeq in prim.
       dur.chron.ther.               at 2-4 wk interv.            hypercholesterolaem./ mix. dyslipidaem./isolat.hypertriglyceridaem.
       Heterozygous famil.hypercholesterolaem: Init.10 mg dly. Dos.  Prim.hypercholesterolaem./mix.dyslipidaem. & isol.hyper-  incl. Fredrickson Type IIa/IIb/&IV & heterozygous familial hypercho-
       indiv.& adjust.4 wkly to 40 mg dly. Thereaft.a bile acid sequestr.may   triglyceridaem: Recomm. start.dos: 5 mg once dly. Pts.of Asian   lesterolaem., homozygous familial hypercholesterolaem.alone or as
       be combin. with 40 mg Vastor.  ancestry & pts.requir.a small.LDL-C reduct. to achiev.treatm.target:   adjunct. to diet & other lipid low.treatm.
       Homozygous famil.hypercholesterolaem: Adults: Most pts.  5 mg start.dos.recomm. Start.dos.of 20 mg may be cons. in sev.hy-  (S4) TABS. 43/7.5/1138, 36/7.5/0353, 0354, 0355
       respond.to 80 mg dos.         percholesterolaem.           723655-001: 5 mg, 28, R86,34
       Contraindications: Concom.ciclospor./protease inhibits., act.liv.  Homozygous familial hypercholesterolaem: Start.recomm.  717520-001: 10 mg, 28, R141,95
       dis./persist.unexpl.elev.ser. transaminas., pregn.& lactat., women   dos: 20 mg once dly.  717521-001: 20 mg, 28, R214,36
       of childbear. potent.not using adeq.contracept.meas., myopathy,   Concom.ther.: Addit.effic.shown with concom. fenofibrate in lower.  717522-001: 40 mg, 28, R260,71
       Child-Pugh B & C liv.cirrhos.  triglycerid.& may incr. HDL-C lev.with niacin. Bile acid sequestrant.  Dosage: Init.& contin.diet ther.bef.& dur.treatm. Indiv. ther.accord.
       Side effects: Freq: Allerg.reacts.incl.anaphylax., incr.ser.gluc.lev.,   or ezetimibe can be used. Max.dos.of 10 mg/day when used with   to ther.goal & pt.respons. Admin. low.dos. provid.ther.benef. Dos.
       headache, dizzin., paraesthes., naus., diarrh., abdom.pain, dyspeps.,   protease inhibits.  range 5-40 mg once dly. Recomm.start.dos: 5 mg once dly. Maj. pts.
       constip., flatul., prurit., skin rash, arthralg., myalg., back/ chest pain,   Init. ther.with 5 mg once dly.& do not exceed 20 mg once dly with   control.on 10 mg dos. If necess.make dos. adjustm. at 2-4 wk.interv.
       asthen., flu syndr., infect. Less freq: Anaem., neutropen., thrombocy-  concom. gemfibrozil.  Prim.hypercholesterolaem.incl.heterozygous familial hy-
       topen., angioed., weight gain, hypo-/hyperglycaem., anorex., periph.   Contraindications: Predispos.myopathy/ rhabdomyolys. act.eg.   percholesterolaem./mix. dyslipidaem. & isol.hypertriglyc-
       neuropathy,, amnes., dysgeus., cognit.impairm., tinnit., hear.loss, pe-  mod.ren.impairm./ hypothyroid./ heredit.musc.disords or hist.thereof   eridaem: Init. dos: 5 mg once dly. Start.dos.of 20 mg may be</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page163.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page159.html">159</a>&nbsp;&nbsp;&nbsp;<a href="page160.html">160</a>&nbsp;&nbsp;&nbsp;<a href="page161.html">161</a>&nbsp;&nbsp;&nbsp;<a href="page162.html">162</a>&nbsp;&nbsp;&nbsp;<a href="page163.html">163</a>&nbsp;&nbsp;&nbsp;<a href="page164.html">164</a>&nbsp;&nbsp;&nbsp;<a href="page165.html">165</a>&nbsp;&nbsp;&nbsp;<a href="page166.html">166</a>&nbsp;&nbsp;&nbsp;<a href="page167.html">167</a>&nbsp;&nbsp;&nbsp;<a href="page168.html">168</a>&nbsp;&nbsp;&nbsp;<a href="page169.html">169</a>
             </td>
             <td width="35%"><a href="page165.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page165.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
